spiperone has been researched along with verapamil in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (44.44) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Brouillette, WJ; Brown, GB; Zha, C | 1 |
Artursson, P; Mateus, A; Matsson, P | 1 |
Casellas, N; Cutillas, B; Ferrani, A; Mahy, N | 1 |
Affolter, H; Burkard, WP; Pletscher, A | 1 |
Leff, P; Morse, JM | 1 |
Defeudis, FV; Taylor, JE | 1 |
Reyes, A; Sitges, M | 1 |
9 other study(ies) available for spiperone and verapamil
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A highly predictive 3D-QSAR model for binding to the voltage-gated sodium channel: design of potent new ligands.
Topics: Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Voltage-Gated Sodium Channels | 2014 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Characterization of D2-dopamine receptor modification in rat striatum after calcium channel blocker treatment.
Topics: Administration, Oral; Animals; Brain; Cinnarizine; Male; Nicardipine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Verapamil | 1990 |
Verapamil, an antagonist at 5-hydroxytryptamine receptors of human blood platelets.
Topics: Adenosine Diphosphate; Binding, Competitive; Blood Platelets; Cerebral Cortex; Gallopamil; Humans; In Vitro Techniques; Ketanserin; Membranes; Piperidines; Receptors, Serotonin; Spiperone; Verapamil | 1985 |
Resultant pharmacological actions of verapamil: quantification of competitive 5-hydroxytryptamine antagonism in combination with calcium antagonism.
Topics: Animals; Calcium Channel Blockers; Dose-Response Relationship, Drug; Kinetics; Male; Mathematics; Rabbits; Serotonin Antagonists; Spiperone; Verapamil | 1987 |
Inhibition of [3H]spiperone binding to 5-HT2 receptors of rat cerebral cortex by the calcium antagonists verapamil and D600.
Topics: Animals; Binding, Competitive; Butyrophenones; Cerebral Cortex; Gallopamil; In Vitro Techniques; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Spiperone; Verapamil | 1984 |
Effects of verapamil on the release of different neurotransmitters.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Biogenic Monoamines; Dopamine; Hippocampus; In Vitro Techniques; Male; Neostriatum; Potassium; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Presynaptic; Receptors, Serotonin; Spiperone; Synaptosomes; Verapamil | 1995 |